Search Results - "Howell, Brett"

Refine Results
  1. 1

    Comparing the Liver Safety Profiles of 4 Next-Generation CGRP Receptor Antagonists to the Hepatotoxic CGRP Inhibitor Telcagepant Using Quantitative Systems Toxicology Modeling by Woodhead, Jeffrey L, Siler, Scott Q, Howell, Brett A, Watkins, Paul B, Conway, Charles

    Published in Toxicological sciences (28-06-2022)
    “…Abstract Calcitonin gene-related peptide (CGRP) signaling inhibitors have shown efficacy in both the acute and preventive treatment of migraine. Telcagepant, a…”
    Get full text
    Journal Article
  2. 2

    Assessing Liver Effects of Cannabidiol and Valproate Alone and in Combination Using Quantitative Systems Toxicology by Lakhani, Vinal V., Generaux, Grant, Howell, Brett A., Longo, Diane M., Watkins, Paul B.

    Published in Clinical pharmacology and therapeutics (01-11-2023)
    “…In clinical trials of cannabidiol (CBD) for the treatment of seizures in patients with Dravet syndrome, Lennox–Gastaut syndrome, and tuberous sclerosis…”
    Get full text
    Journal Article
  3. 3

    Quantitative Systems Toxicology Modeling Informed Safe Dose Selection of Emvododstat in Acute Myeloid Leukemia Patients by Yang, Kyunghee, Kong, Ronald, Spiegel, Robert, Baird, John D., O'Keefe, Kylie, Howell, Brett A., Watkins, Paul B.

    Published in Clinical pharmacology and therapeutics (01-03-2024)
    “…Clinical investigation of emvododstat for the treatment of solid tumors was halted after two patients who were heavily treated with other anticancer therapies…”
    Get full text
    Journal Article
  4. 4

    Analyzing the Mechanisms Behind Macrolide Antibiotic-Induced Liver Injury Using Quantitative Systems Toxicology Modeling by Woodhead, Jeffrey L., Yang, Kyunghee, Oldach, David, MacLauchlin, Chris, Fernandes, Prabhavathi, Watkins, Paul B., Siler, Scott Q., Howell, Brett A.

    Published in Pharmaceutical research (01-03-2019)
    “…Purpose Macrolide antibiotics are commonly prescribed treatments for drug-resistant bacterial infections; however, many macrolides have been shown to cause…”
    Get full text
    Journal Article
  5. 5

    Prediction of the liver safety profile of a first-in-class myeloperoxidase inhibitor using quantitative systems toxicology modeling by Woodhead, Jeffrey L, Gebremichael, Yeshi, Macwan, Joyce, Qureshi, Irfan A, Bertz, Richard, Wirtz, Victoria, Howell, Brett A

    Published in Xenobiotica (08-08-2024)
    “…The novel myeloperoxidase inhibitor verdiperstat was developed as a treatment for neuroinflammatory and neurodegenerative diseases. During development, a…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury by Yang, Kyunghee, Guo, Cen, Woodhead, Jeffrey L, St Claire, 3rd, Robert L, Watkins, Paul B, Siler, Scott Q, Howell, Brett A, Brouwer, Kim L R

    Published in Journal of pharmaceutical sciences (01-02-2016)
    “…Sandwich-cultured hepatocytes (SCH) are metabolically competent and have proper localization of basolateral and canalicular transporters with functional bile…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Variable responses of karst springs to recharge in the Middle Atlas region of Morocco by Howell, Brett A., Fryar, Alan E., Benaabidate, Lahcen, Bouchaou, Lhoussaine, Farhaoui, Mohamed

    Published in Hydrogeology journal (01-08-2019)
    “…Springs in the Middle Atlas region of Morocco are important public water supplies, but their responses to storm-event and seasonal forcings have received only…”
    Get full text
    Journal Article
  10. 10

    The role of quantitative systems pharmacology modeling in the prediction and explanation of idiosyncratic drug-induced liver injury by Woodhead, Jeffrey L., Watkins, Paul B., Howell, Brett A., Siler, Scott Q., Shoda, Lisl K.M.

    Published in Drug metabolism and pharmacokinetics (01-02-2017)
    “…Idiosyncratic drug-induced liver injury (iDILI) is a serious concern in drug development. The rarity and multifactorial nature of iDILI makes it difficult to…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Assessing Effects of BHV-0223 40 mg Zydis Sublingual Formulation and Riluzole 50 mg Oral Tablet on Liver Function Test Parameters Utilizing DILIsym by Longo, Diane M, Shoda, Lisl K M, Howell, Brett A, Coric, Vladimir, Berman, Robert M, Qureshi, Irfan A

    Published in Toxicological sciences (01-06-2020)
    “…Abstract For patients with amyotrophic lateral sclerosis who take oral riluzole tablets, approximately 50% experience alanine transaminase (ALT) levels above…”
    Get full text
    Journal Article
  13. 13

    Investigating bile acid-mediated cholestatic drug-induced liver injury using a mechanistic model of multidrug resistance protein 3 (MDR3) inhibition by Beaudoin, James J, Yang, Kyunghee, Adiwidjaja, Jeffry, Taneja, Guncha, Watkins, Paul B, Siler, Scott Q, Howell, Brett A, Woodhead, Jeffrey L

    Published in Frontiers in pharmacology (17-01-2023)
    “…Inhibition of the canalicular phospholipid floppase multidrug resistance protein 3 (MDR3) has been implicated in cholestatic drug-induced liver injury (DILI),…”
    Get full text
    Journal Article
  14. 14

    Use of a systems model of drug-induced liver injury (DILIsym®) to elucidate the mechanistic differences between acetaminophen and its less-toxic isomer, AMAP, in mice by Howell, Brett A., Siler, Scott Q., Watkins, Paul B.

    Published in Toxicology letters (21-04-2014)
    “…Acetaminophen (APAP) has been used as a probe drug to investigate drug-induced liver injury (DILI). In mice, 3′-hydroxyacetanilide (AMAP), a less-toxic isomer…”
    Get full text
    Journal Article
  15. 15

    Mechanisms of hepatotoxicity associated with the monocyclic β-lactam antibiotic BAL30072 by Paech, Franziska, Messner, Simon, Spickermann, Jochen, Wind, Mathias, Schmitt-Hoffmann, Anne-Hortense, Witschi, Anne Therese, Howell, Brett A., Church, Rachel J., Woodhead, Jeff, Engelhardt, Marc, Krähenbühl, Stephan, Maurer, Martina

    Published in Archives of toxicology (01-11-2017)
    “…BAL30072 is a new monocyclic β-lactam antibiotic under development which provides a therapeutic option for the treatment of severe infections caused by…”
    Get full text
    Journal Article
  16. 16

    Using Quantitative Systems Toxicology to Investigate Observed Species Differences in CKA-Mediated Hepatotoxicity by Battista, Christina, Yang, Kyunghee, Stahl, Simone H, Mettetal, Jerome T, Watkins, Paul B, Siler, Scott Q, Howell, Brett A

    Published in Toxicological sciences (01-11-2018)
    “…Abstract CKA, a chemokine receptor antagonist intended for treating inflammatory conditions, produced dose-dependent hepatotoxicity in rats but advanced into…”
    Get full text
    Journal Article
  17. 17

    Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury by Woodhead, Jeffrey L, Yang, Kyunghee, Siler, Scott Q, Watkins, Paul B, Brouwer, Kim L R, Barton, Hugh A, Howell, Brett A

    Published in Frontiers in pharmacology (2014)
    “…Inhibition of the bile salt export pump (BSEP) has been linked to incidence of drug-induced liver injury (DILI), presumably by the accumulation of toxic bile…”
    Get full text
    Journal Article
  18. 18

    Interaction of Cationic Drugs with Liposomes by Howell, Brett A, Chauhan, Anuj

    Published in Langmuir (20-10-2009)
    “…Interactions between cationic drugs and anionic liposomes were studied by measuring binding of drugs and the effect of binding on liposome permeability. The…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Linking physiology to toxicity using DILIsym®, a mechanistic mathematical model of drug-induced liver injury by Shoda, Lisl K. M., Woodhead, Jeffrey L., Siler, Scott Q., Watkins, Paul B., Howell, Brett A.

    Published in Biopharmaceutics & drug disposition (01-01-2014)
    “…ABSTRACT The drug development industry faces multiple challenges in the realization of safe effective drugs. Computational modeling approaches can be used to…”
    Get full text
    Journal Article